Single-Cell Image-Based Analysis Reveals Chromatin Changes during the Acquisition of Tamoxifen Drug Resistance

Single-Cell Image-Based Analysis Reveals Chromatin Changes during the Acquisition of Tamoxifen Drug Resistance

Cancer drug resistance is the leading cause of cancer related deaths. The development of drug resistance can be partially contributed to tumor heterogeneity and epigenetic plasticity. However, the detailed molecular mechanism underlying epigenetic modulated drug resistance remains elusive. In this w...

Full description

Saved in:
Bibliographic Details
Published in:Life (Basel, Switzerland) Vol. 12; no. 3; p. 438
Main Authors: Zhao, Han, Lin, Li F, Hahn, Joshua, Xie, Junkai, Holman, Harvey F, Yuan, Chongli
Format: Journal Article
Language:English
Published: Switzerland MDPI AG 17-03-2022
MDPI
Subjects:
Breast cancer
Cancer therapies
Chromatin
Clustering
Deoxyribonucleic acid
DNA
DNA methylation
DNA probes
Drug resistance
Epigenetics
Genomes
Heterochromatin
Heterogeneity
Hypotheses
Image acquisition
Image processing
Phenotypes
Probes
Stem cells
Tamoxifen
Tumor cell lines
Tumors
United States > US
breast cancer
drug resistance
chromatin
epigenetics
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cancer drug resistance is the leading cause of cancer related deaths. The development of drug resistance can be partially contributed to tumor heterogeneity and epigenetic plasticity. However, the detailed molecular mechanism underlying epigenetic modulated drug resistance remains elusive. In this work, we systematically analyzed epigenetic changes in tamoxifen (Tam) responsive and resistant breast cancer cell line MCF7, and adopted a data-driven approach to identify key epigenetic features distinguishing between these two cell types. Significantly, we revealed that DNA methylation and H3K9me3 marks that constitute the heterochromatin are distinctively different between Tam-resistant and -responsive cells. We then performed time-lapse imaging of 5mC and H3K9me3 features using engineered probes. After Tam treatment, we observed a slow transition of MCF7 cells from a drug-responsive to -resistant population based on DNA methylation features. A similar trend was not observed using H3K9me3 probes. Collectively, our results suggest that DNA methylation changes partake in the establishment of Tam-resistant breast cancer cell lines. Instead of global changes in the DNA methylation level, the distribution of DNA methylation features inside the nucleus can be one of the drivers that facilitates the establishment of a drug resistant phenotype in MCF7.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2075-1729
2075-1729
DOI:10.3390/life12030438